Documentos relacionados

1. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
2. Evolving use of new oral anticoagulants for treatment of venous thromboembolism.
3. Treatment of venous thromboembolism with dabigatran.
4. Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study.
5. Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
6. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
7. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.
8. [New evidence in the secondary prevention of thromboembolic disease].
9. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
10. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.